Security
Pediatrix Medical Group, Inc. · MD
MDNYSECommon stockCurrentCIK 893949Updated Oct 30, 2026
Name history
MEDNAX, INC. · through Jun 21, 2022PEDIATRIX MEDICAL GROUP INC · through Jan 2, 2009
MD price & chart
Loading TradingView…
NYSE:MD on TradingView ↗About the company
Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Specialties include obstetrics, maternal-fetal medicine and neonatology complemented by multiple pediatric subspecialties. The group’s high-quality, evidence-based care is bolstered by significant investments in research, education, quality-improvement and safety initiatives. The physician-led company was founded in 1979 as a single neonatology practice and today provides its highly specialized and often critical care services through approximately 4,300 affiliated physicians and other clinicians. To learn more about Pediatrix, visit www.pediatrix.com or follow us on Facebook, Instagram, LinkedIn and the Pediatrix blog. Investment information can be found at www.pediatrix.com/about/investors.
In the news
No coverage from other publishers is available.
Seeking Alpha
Pediatrix Medical Group, Inc. (MD) Q3 2026 Earnings Call Transcript ↗
Here are the major earnings before the open Thursday ↗
SEC disclosures
Pediatrix Medical Group, Inc. files 8-K: Material Event ↗
Recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 2,199,405,000Source | 2,076,873,000Source | 2,130,342,000Source | 2,102,100,000Source | 1,995,351,000Source | 2,070,295,000Source | 1,993,479,000Source | 2,168,165,000Source | 2,246,696,000Source | 2,152,700,000Source | 2,219,810,000Source | 2,347,887,000Source |
| Property, Plant and Equipment, NetUSD | 38,636,000Source | 41,922,000Source | 38,704,000Source | 38,944,000Source | 47,893,000Source | 41,094,000Source | 38,222,000Source | 74,340,000Source | 39,180,000Source | 39,172,000Source | 75,639,000Source | 73,290,000Source |
| GoodwillUSD | 1,255,423,000Source | 1,239,007,000Source | 1,268,248,000Source | 1,242,606,000Source | 1,239,007,000Source | 1,268,248,000Source | 1,242,606,000Source | 1,393,249,000Source | 1,260,732,000Source | 1,242,606,000Source | 1,384,166,000Source | 1,532,092,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 340,059,000Source | 103,831,000Source | 288,879,000Source | 224,732,000Source | 19,402,000Source | 205,780,000Source | 98,978,000Source | 7,998,000Source | 375,241,000Source | 229,940,000Source | 73,258,000Source | 9,824,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 231,122,000Source | 286,897,000Source | 227,601,000Source | 238,992,000Source | 274,164,000Source | 224,801,000Source | 242,529,000Source | 283,749,000Source | 229,665,000Source | 259,990,000Source | 272,313,000Source | 296,787,000Source |
| Assets, CurrentUSD | 717,195,000Source | 528,215,000Source | 660,141,000Source | 613,050,000Source | 429,212,000Source | 587,034,000Source | 491,670,000Source | 426,523,000Source | 763,514,000Source | 639,607,000Source | 483,454,000Source | 427,989,000Source |
| Operating Lease, Right-of-Use AssetUSD | — | — | — | — | — | — | — | — | 31,132,000Source | 34,089,000Source | 61,693,000Source | 55,796,000Source |
| Other Assets, NoncurrentUSD | 57,889,000Source | 78,594,000Source | 57,431,000Source | 70,785,000Source | 79,539,000Source | 55,403,000Source | 71,349,000Source | 83,074,000Source | 58,156,000Source | 76,598,000Source | 82,165,000Source | 123,176,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 1,308,739,000Source | 1,344,381,000Source | 1,249,365,000Source | 1,268,347,000Source | 1,288,890,000Source | 1,191,719,000Source | 1,204,291,000Source | 1,311,969,000Source | 1,380,842,000Source | 1,387,762,000Source | 1,370,749,000Source | 1,456,255,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 858,000Source | 859,000Source | 812,000Source | 869,000Source | 858,000Source | 821,000Source | 858,000Source | 840,000Source | 830,000Source | 859,000Source | 840,000Source | 829,000Source |
| Retained Earnings (Accumulated Deficit)USD | -116,835,000Source | -279,020,000Source | -13,737,000Source | -188,543,000Source | -298,461,000Source | -53,580,000Source | -227,803,000Source | -145,436,000Source | -83,152,000Source | -248,540,000Source | 149,471,000Source | -89,063,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 446,000Source | -209,000Source | -386,000Source | 137,000Source | -1,954,000Source | 77,000Source | -292,000Source | -2,154,000Source | 610,000Source | -1,071,000Source | 2,214,000Source | -3,735,000Source |
| Stockholders' Equity Attributable to ParentUSD | 890,666,000Source | 732,492,000Source | 880,977,000Source | 833,753,000Source | 706,461,000Source | 878,576,000Source | 789,188,000Source | 856,196,000Source | 865,854,000Source | 764,938,000Source | 849,061,000Source | 891,632,000Source |
| Additional Paid in Capital, Common StockUSD | 1,006,197,000Source | 1,010,862,000Source | 894,288,000Source | 1,021,290,000Source | 1,006,018,000Source | 931,258,000Source | 1,016,425,000Source | 1,002,946,000Source | 947,566,000Source | 1,013,690,000Source | 999,906,000Source | 983,601,000Source |
| Liabilities and EquityUSD | 2,199,405,000Source | 2,076,873,000Source | 2,130,342,000Source | 2,102,100,000Source | 1,995,351,000Source | 2,070,295,000Source | 1,993,479,000Source | 2,168,165,000Source | 2,246,696,000Source | 2,152,700,000Source | 2,219,810,000Source | 2,347,887,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 392,547,000Source | 373,080,000Source | 501,578,000Source | 341,043,000Source | 310,156,000Source | 442,638,000Source | 271,052,000Source | 247,282,000Source | 458,911,000Source | 434,110,000Source | 388,946,000Source | 426,983,000Source |
| Operating Lease, Liability, CurrentUSD | 12,226,000Source | 16,992,000Source | 12,238,000Source | 12,049,000Source | 18,764,000Source | 11,885,000Source | 12,174,000Source | 21,034,000Source | 11,591,000Source | 12,704,000Source | 21,076,000Source | 21,589,000Source |
| Accounts Payable, CurrentUSD | 38,652,000Source | 47,367,000Source | 27,849,000Source | 42,065,000Source | 32,000,000Source | 31,537,000Source | 44,120,000Source | 31,636,000Source | 37,220,000Source | 46,431,000Source | 34,588,000Source | 31,857,000Source |
| Operating Lease, Liability, NoncurrentUSD | 27,533,000Source | 39,940,000Source | 23,475,000Source | 29,963,000Source | 49,176,000Source | 27,061,000Source | 30,538,000Source | 47,873,000Source | 25,686,000Source | 31,945,000Source | 47,238,000Source | 44,213,000Source |
| Deferred Income Tax Liabilities, NetUSD | 38,285,000Source | 35,618,000Source | 58,709,000Source | 36,019,000Source | 30,627,000Source | 57,002,000Source | 34,424,000Source | 34,105,000Source | 57,024,000Source | 34,246,000Source | 34,308,000Source | 33,638,000Source |
| Other Liabilities, NoncurrentUSD | 33,526,000Source | 33,035,000Source | 32,398,000Source | 33,297,000Source | 31,521,000Source | 29,721,000Source | 30,859,000Source | 33,492,000Source | 30,336,000Source | 32,887,000Source | 30,552,000Source | 39,411,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Additional Financial Items | ||||||||||||
| Long-term DebtUSD | — | — | — | — | — | — | — | — | — | 611,200,000Source | 622,200,000Source | 637,200,000Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | 71,708,000Source | 19,441,000Source | — | 39,260,000Source | — | 20,737,000Source | 165,388,000Source | -99,069,000Source | -60,408,000Source | 66,331,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | 5,551,000Source | 6,254,000Source | 5,782,000Source | 5,313,000Source | 6,119,000Source | 5,332,000Source | 21,827,000Source | 32,226,000Source | 36,171,000Source | 35,636,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 4,661,000Source | 3,641,000Source | 18,045,000Source | 11,868,000Source | 12,323,000Source | 16,127,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -4,864,000Source | -17,461,000Source | -30,558,000Source | -10,292,000Source | -26,276,000Source | 5,543,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | 8,342,000Source | 4,398,000Source | 52,186,000Source | -2,130,000Source | 3,239,000Source | -22,771,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -129,847,000Source | -117,463,000Source | 271,091,000Source | 206,573,000Source | 137,325,000Source | 166,941,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | 7,000,000Source | 0Source | 23,196,000Source | 8,167,000Source | 6,667,000Source | 28,167,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -11,979,000Source | -7,464,000Source | -18,296,000Source | -35,406,000Source | -48,176,000Source | -56,954,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | — | — | — | — | — | — | -526,000Source | 3,685,000Source | 3,465,000Source | — | — | — |
| Cash flows from financing activities: | ||||||||||||
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | 21,451,000Source | 1,569,000Source | 86,683,000Source | 1,703,000Source | 919,000Source | 88,511,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -27,635,000Source | -6,035,000Source | -107,494,000Source | -14,485,000Source | -25,715,000Source | -487,554,000Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | — | — | — | — | — | — | 0Source | -101,000Source | -63,000Source | 135,000Source | -8,773,000Source | 9,353,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -169,461,000Source | -130,962,000Source | 145,301,000Source | 156,682,000Source | 63,434,000Source | -377,567,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | — | 34,382,000Source | 40,003,000Source | 42,278,000Source | 116,235,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 1,715,000Source | 4,673,000Source | 30,835,000Source | 26,908,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 3,400,000Source | 2,600,000Source | — | 2,000,000Source | 3,700,000Source | 2,300,000Source | 11,700,000Source | 9,900,000Source | 12,300,000Source | 14,400,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | — | — | — | — | 103,000Source | 230,000Source | 935,000Source | 954,000Source | 1,239,000Source | 1,765,000Source |
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | 5,700,000Source | 7,100,000Source | 5,600,000Source | 6,400,000Source |
| DepreciationUSD | — | — | — | — | — | — | — | — | 14,300,000Source | 22,700,000Source | 28,100,000Source | 26,700,000Source |
| Gain (Loss) on InvestmentsUSD | — | — | — | — | — | — | — | — | 20,906,000Source | — | — | — |
| Gain (Loss) on Disposition of BusinessUSD | — | — | 0Source | -59,000Source | — | 0Source | — | — | 0Source | -9,699,000Source | — | — |
| Gain (Loss) on Sale of InvestmentsUSD | — | — | 20,906,000Source | 0Source | — | — | — | — | 20,906,000Source | — | — | — |
| Gain (Loss) on Sale of PropertiesUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 0Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | -57,016,000Source |
| General and Administrative ExpenseUSD | — | — | 60,793,000Source | 58,121,000Source | 61,291,000Source | 55,714,000Source | 60,266,000Source | 58,604,000Source | 240,791,000Source | 238,437,000Source | 227,542,000Source | 231,397,000Source |
| GoodwillUSD | — | — | 1,255,423,000Source | 1,239,007,000Source | 1,268,248,000Source | 1,242,606,000Source | 1,268,248,000Source | 1,242,606,000Source | 1,260,732,000Source | 1,242,606,000Source | 1,384,166,000Source | 1,532,092,000Source |
| Goodwill and Intangible Asset ImpairmentUSD | — | — | — | — | — | — | — | — | 0Source | 178,435,000Source | 168,312,000Source | — |
| Goodwill, Impairment LossUSD | — | — | 0Source | 0Source | — | 0Source | — | — | — | 150,644,000Source | 148,312,000Source | — |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)USD | — | — | — | — | — | — | — | — | — | 7,700,000Source | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | -99,069,000Source | -60,408,000Source | 62,564,000Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | 3,767,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | 1,879,000Source | 445,000Source | 702,000Source | 505,000Source | 692,000Source | 406,000Source | 3,633,000Source | 2,344,000Source | 2,057,000Source | 1,722,000Source |
| Income Tax Expense (Benefit)USD | — | — | 16,070,000Source | 5,794,000Source | 14,157,000Source | 15,709,000Source | 9,272,000Source | 7,353,000Source | 51,044,000Source | -2,272,000Source | 12,049,000Source | 18,806,000Source |
| InterestExpenseNonoperatingUSD | — | — | 8,941,000Source | 10,126,000Source | 8,172,000Source | 9,130,000Source | 8,265,000Source | 9,154,000Source | 35,965,000Source | 40,743,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | 71,708,000Source | 19,441,000Source | 39,843,000Source | 39,260,000Source | 29,572,000Source | 20,737,000Source | 165,388,000Source | -99,069,000Source | -60,408,000Source | 66,335,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | -4,000Source |
| Nonoperating Income (Expense)USD | — | — | 19,727,000Source | -8,592,000Source | -2,922,000Source | -4,898,000Source | -2,813,000Source | -4,011,000Source | 7,619,000Source | -32,628,000Source | -55,680,000Source | -91,318,000Source |
| Operating ExpensesUSD | — | — | 424,824,000Source | 477,331,000Source | 430,861,000Source | 408,977,000Source | 434,539,000Source | 426,258,000Source | 1,705,036,000Source | 2,081,632,000Source | 1,987,319,000Source | 1,799,333,000Source |
| Operating Lease, Impairment LossUSD | — | — | — | — | — | — | — | — | — | 12,500,000Source | — | — |
| Payments of Financing CostsUSD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | 8,621,000Source |
| Payments to Acquire InvestmentsUSD | — | — | — | — | — | — | 7,008,000Source | 7,761,000Source | 29,851,000Source | 64,546,000Source | 31,893,000Source | 17,346,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 544,000Source | 662,000Source | 3,184,000Source | 3,638,000Source | 4,912,000Source | 5,396,000Source |
| Proceeds from Noncontrolling InterestsUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | 492,875,000Source | 511,158,000Source | 487,783,000Source | 468,844,000Source | 476,196,000Source | 458,359,000Source | 1,913,849,000Source | 2,012,919,000Source | 1,994,640,000Source | 1,972,021,000Source |
| Unrealized Gain (Loss) on InvestmentsUSD | — | — | 309,000Source | 1,745,000Source | -463,000Source | 429,000Source | -533,000Source | 779,000Source | 1,681,000Source | 1,143,000Source | 1,521,000Source | -5,051,000Source |
| AssetAcquisitionContingentConsiderationLiability | — | — | —Source | — | — | — | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income (Loss)USD | — | — | 68,051,000Source | 33,827,000Source | 56,922,000Source | 59,867,000Source | 41,657,000Source | 32,101,000Source | 208,813,000Source | -68,713,000Source | 7,321,000Source | 172,688,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | 87,778,000Source | 25,235,000Source | 54,000,000Source | 54,969,000Source | 38,844,000Source | 28,090,000Source | 216,432,000Source | -101,341,000Source | -48,359,000Source | 81,370,000Source |
| Income Tax Expense (Benefit)USD | — | — | 16,070,000Source | 5,794,000Source | 14,157,000Source | 15,709,000Source | 9,272,000Source | 7,353,000Source | 51,044,000Source | -2,272,000Source | 12,049,000Source | 18,806,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | -4,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 71,708,000Source | 19,441,000Source | 39,843,000Source | 39,260,000Source | 29,572,000Source | 20,737,000Source | 165,388,000Source | -99,069,000Source | -60,408,000Source | 66,335,000Source |
| Earnings Per Share, BasicUSD per share | — | — | 0.85Source | 0.23Source | 0.5Source | 0.46Source | 0.37Source | 0.25Source | 1.97Source | -1.19Source | 0.73Source | 0.79Source |
| Earnings Per Share, DilutedUSD per share | — | — | 0.84Source | 0.23Source | 0.49Source | 0.46Source | 0.36Source | 0.24Source | 1.94Source | -1.19Source | 0.73Source | 0.79Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 84,609,000Source | 83,891,000Source | 79,440,000Source | 84,797,000Source | 80,881,000Source | 84,435,000Source | 84,080,000Source | 83,330,000Source | 82,201,000Source | 83,467,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 85,613,000Source | 84,523,000Source | 81,412,000Source | 85,529,000Source | 83,075,000Source | 85,430,000Source | 85,268,000Source | 83,330,000Source | 82,201,000Source | 84,121,000Source |
| Interest Expense (non-operating)USD | — | — | 8,941,000Source | 10,126,000Source | 8,172,000Source | 9,130,000Source | 8,265,000Source | 9,154,000Source | 35,965,000Source | 40,743,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | 5,700,000Source | 7,100,000Source | 5,600,000Source | 6,400,000Source |
| Gain (Loss) on InvestmentsUSD | — | — | — | — | — | — | — | — | 20,906,000Source | — | — | — |
| General and Administrative ExpenseUSD | — | — | 60,793,000Source | 58,121,000Source | 61,291,000Source | 55,714,000Source | 60,266,000Source | 58,604,000Source | 240,791,000Source | 238,437,000Source | 227,542,000Source | 231,397,000Source |
| Goodwill, Impairment LossUSD | — | — | 0Source | 0Source | — | 0Source | — | — | — | 150,644,000Source | 148,312,000Source | — |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | -99,069,000Source | -60,408,000Source | 62,564,000Source |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | — | — | — | — | — | — | — | — | — | -1.19Source | 0.73Source | 0.75Source |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | — | — | — | — | — | — | — | — | — | -1.19Source | 0.73Source | 0.74Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | 3,767,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | 1,879,000Source | 445,000Source | 702,000Source | 505,000Source | 692,000Source | 406,000Source | 3,633,000Source | 2,344,000Source | 2,057,000Source | 1,722,000Source |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 42,075,000Source | 39,695,000Source |
| Investment Income, NetUSD | — | — | 5,883,000Source | 1,089,000Source | 4,548,000Source | 3,727,000Source | 4,760,000Source | 4,737,000Source | 19,045,000Source | 5,771,000Source | 4,338,000Source | 3,671,000Source |
| Nonoperating Income (Expense)USD | — | — | 19,727,000Source | -8,592,000Source | -2,922,000Source | -4,898,000Source | -2,813,000Source | -4,011,000Source | 7,619,000Source | -32,628,000Source | -55,680,000Source | -91,318,000Source |
| Operating ExpensesUSD | — | — | 424,824,000Source | 477,331,000Source | 430,861,000Source | 408,977,000Source | 434,539,000Source | 426,258,000Source | 1,705,036,000Source | 2,081,632,000Source | 1,987,319,000Source | 1,799,333,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | 492,875,000Source | 511,158,000Source | 487,783,000Source | 468,844,000Source | 476,196,000Source | 458,359,000Source | 1,913,849,000Source | 2,012,919,000Source | 1,994,640,000Source | 1,972,021,000Source |
Filing attachments
md-ex99_1.htm · 8-K · 2026-10-29
FOR MORE INFORMATION: Kasandra H. Rossi Executive Vice President, Chief Financial Officer & Treasurer 954-692-7163 kasandra.rossi@pediatrix.com FOR IMMEDIATE RELEASE Pediatrix Medical Group Reports Third Quarter Results FORT LAUDERDALE, Fla., October 29, 2026 - Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today reported earnings of $0.59 per share for the three months ended September 30, 2026. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $…
Read attachment ↗md-ex99_1.htm · 8-K · 2026-08-04
EX-99.1 2 md-ex99_1.htm EX-99.1 EX-99.1 FOR MORE INFORMATION: Kasandra H. Rossi Executive Vice President, Chief Financial Officer & Treasurer 954-692-7163 kasandra.rossi@pediatrix.com FOR IMMEDIATE RELEASE Pediatrix Medical Group Reports Second Quarter Results FORT LAUDERDALE, Fla., August 4, 2026 - Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today reported earnings of $0.49 per share for the three months ended June 30, 2026. On a non-GAAP basi…
Read attachment ↗md-ex99_1.htm · 8-K · 2026-07-15
EX-99.1 2 md-ex99_1.htm EX-99.1 EX-99.1 FOR MORE INFORMATION: Kasandra H. Rossi Executive Vice President, Chief Financial Officer & Treasurer 954-692-7163 kasandra.rossi@pediatrix.com FOR IMMEDIATE RELEASE Pediatrix Medical Group Provides Second Quarter Update FORT LAUDERDALE, Fla., July 15, 2026 - Pediatrix Medical Group, Inc. (NYSE: MD) (“Pediatrix” or “the Company”), a leading provider of physician services, today provided an update on its second quarter 2026 business trends. In …
Read attachment ↗md-ex99_1.htm · 8-K · 2026-05-05
EX-99.1 2 md-ex99_1.htm EX-99.1 EX-99.1 FOR MORE INFORMATION: Kasandra H. Rossi Executive Vice President, Chief Financial Officer & Treasurer 954-692-7163 kasandra.rossi@pediatrix.com FOR IMMEDIATE RELEASE Pediatrix Medical Group Reports First Quarter Results FORT LAUDERDALE, Fla., May 5, 2026 - Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today reported earnings of $0.36 per share for the three months ended March 31, 2026. On a non-GAAP basis, …
Read attachment ↗md-ex99_1.htm · 8-K · 2026-02-19
FOR MORE INFORMATION: Kasandra H. Rossi Executive Vice President, Chief Financial Officer & Treasurer 954-692-7163 kasandra.rossi@pediatrix.com FOR IMMEDIATE RELEASE Pediatrix Medical Group Reports Fourth Quarter Results FORT LAUDERDALE, Fla., February 19, 2026 - Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today reported earnings of $0.40 per share for the three months ended December 31, 2025. On a non-GAAP basis, Pediatrix reported Adjusted EPS of …
Read attachment ↗md-ex99_1.htm · 8-K · 2025-11-03
EX-99.1 2 md-ex99_1.htm EX-99.1 EX-99.1 FOR MORE INFORMATION: Kasandra H. Rossi Executive Vice President, Chief Financial Officer & Treasurer 954-692-7163 kasandra.rossi@pediatrix.com FOR IMMEDIATE RELEASE Pediatrix Medical Group Reports Third Quarter Results Raises Full Year 2025 Adjusted EBITDA Outlook Range FORT LAUDERDALE, Fla., November 3, 2025 - Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today reported earnings of $0.84 per share for th…
Read attachment ↗